Cloudbreak Therapeutics, LLC
Records under this name other than the patents Cloudbreak Therapeutics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 9 of 9 · Back to Cloudbreak Therapeutics, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,335,408 | Compositions and Methods of Using Nintedanib for Improving Glaucoma Surgery Success Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,688,092 | Compositions and Methods of Using Nintedanib for Improving Glaucoma Surgery Success Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,911,379 | Compositions and Methods of Using Nintedanib for Treating Ocular Diseases with Abnormal Neovascularization Formerly held In force · High confidence | In force | High confidence | |
| US 12,491,183 | Compositions and Methods of Using Nintedanib for Treating Ocular Diseases with Abnormal Neovascularization Formerly held In force · High confidence | In force | High confidence | |
| US 11,179,388 | Topical composition for treating rosacea and a method for treating rosacea with the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,744,153 | Compositions and methods for treating meibomian gland dysfunction Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,166,977 | Compositions for treating meibomian gland dysfunction Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,007,214 | Compositions and methods for treating eye diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,156,873 | Composition for treating ocular hyperemia and a method for treating ocular hyperemia with the same Formerly held In force · From the USPTO record | In force | From the USPTO record |